Glaxosmithkline Regulatory News (GSK)

Name of applicant:

GSK plc

Name of scheme:

GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan

Period of return:

From:

1 May 2023

To:

31 October 2023

Balance of unallotted securities under scheme(s) from previous return:

271,307

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

271,307

Name of applicant:

GSK plc

Name of scheme:

GlaxoSmithKline plc Share Save Plan 2012

Period of return:

From:

1 May 2023

To:

31 October 2023

Balance of unallotted securities under scheme(s) from previous return:

558,829

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

52,231

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

506,598

Name of applicant:

GSK plc

Name of scheme:

GlaxoSmithKline plc Share Save Plan 2022

Period of return:

From:

1 May 2023

To:

31 October 2023

Balance of unallotted securities under scheme(s) from previous return:

999,954

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

845

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

999,109

Name of contact:

Victoria Whyte

Telephone number of contact:

020 8047 5000